Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Enlyte: Migraine Medications Continue Rising in Workers’ Comp
Enlyte's 2025 Drug Trends Report shows rise in migraine medications while opioid use declines in workers' compensation claims.
Enlyte Drug Trend Report: Migraine Med Use Soars in Comp Despite Overall Drop in Scripts
Despite opioids continuing its hold as the most-prescribed drug class in workers’ compensation, migraine medications and topicals are gaining ground as alternatives to pain management, according to part 1 of Enlyte’s 2025 Drug Trends Report.
Bill Review is Complex… Here’s How to Make it Easier and More Efficient
In our Leaders Speak article, Steve Laudermilch shares how to simplify specialty bill review, boost efficiency, and maximize savings.
Mitchell Launches Cloud-Native Guidewire Integration to Help Insurers Expedite Claims Processing
Mitchell today announced the availability of its cloud-native integration for Guidewire ClaimCenter. The new integration optimizes loss profiling, assignment and damage appraisal workflows by automatically synchronizing data from Guidewire and Mitchell applications, helping auto insurers reduce leakage and expedite claims processing.
Diabetes complicates claims, worker recovery
Explore how diabetes complicates workers' compensation claims and impacts injured workers' recovery, highlighting challenges for employers, insurers, and healthcare providers.
‘Psychological injury’ bill could create double remedy for workers
Brian Allen, Enlyte’s VP of Government Affairs, was recently featured in Business Insurance to share his perspective on a new Rhode Island legislative proposal that could significantly impact employers.